A lot of that fear is the misinformation that has been quite deliberately sent out.
Janice Schakowsky
The Public Record
Janice D. Schakowsky is an American politician serving as the U.S. Representative for Illinois's 9th congressional district since 1999. A member of the Democratic Party, she has been a prominent advocate for various progressive issues, including healthcare reform, women's rights, and consumer protection. Schakowsky has played a significant role in shaping policies related to social justice and economic equality throughout her tenure in Congress.
The refusal of my Republican colleagues to appropriate HHS adequate resources to help implement the law is limiting our efforts to inform Americans about Obamacare's exciting new coverage options.
I would challenge my colleagues on the other side to go out and explain to at least some of their constituents--for example, the parents of children with preexisting conditions--that they want to take away insurance to them.
I do urge my colleagues to oppose this bill. We can and should do better, and I'm hopeful that we still will do better.
I would agree that we should be concerned if that is the case and we need to promote that U.S. is the best place to invest.
I agree that we should consider ways to increase investment in this country, both domestic and foreign.
So I commend the Department of Commerce for seeking to resume this collection.
So my question is, if you could tell me what the Department of Commerce is doing, what you are doing, your administration is doing to distinguish between these two types of foreign direct investment...
A portion of your testimony is rights provided to foreign investors should not exceed rights of domestic investors.
If the vast majority of FDI is used to acquire preexisting United States' businesses that were previously owned by Americans, I am less clear about the benefits.
I have a question about greenfield investment, new investment versus merger and acquisitions.
Our drug supply needs to have FDA oversight and drug compounders shouldn't get to create--to evade regulation by the agency.
The compounders have traditionally been adamantly opposed to any expansion of FDA authority over drug compounders.
I mean, we would have press conferences every 6 months or so, and parents and grandparents would come holding pictures of their children that they had literally killed.
I was the lead sponsor, along with my Republican colleague Peter King, of the Cameron Gulbransen Kids Transportation Safety Act of 2007.
This is the subcommittee's third hearing of the year and the third in our series on manufacturing--a critical sector of our economy that creates good jobs for American workers.
The infrastructure issue really is critical, so you are saying that the technology is all there, but--and Maryland has made a commitment.
Now that we have other manufacturers is there anyone who doesn't agree that some sort of a national certification or standard of competency would be helpful, so that is a good direction to go in.
Let me just ask you this, because obviously it is my view that everyone should have access to rear visibility and other safety features.
The American Society of Civil Engineers reported this week that our national infrastructure is rated as a D plus.





